Latest receivables for GHSI: $13K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Guardion Health Sciences (GHSI) currently reports a receivables of $13K as of June 2024. That compares with $1.6M in the prior-year period — down 99.2% year over year. Use the charts on this page to explore Guardion Health Sciences's receivables history and peer comparisons.
Guardion Health Sciences's receivables decreased from $1.6M to $13K — a 99.2% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Guardion Health Sciences reported $13K in receivables as of June 2024. That compares with $1.6M in the prior-year period — down 99.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $13K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Guardion Health Sciences, and consider following GHSI for alerts when major investors trade the stock.
Guardion Health Sciences is classified in the Healthcare sector. On receivables, it currently shows $13K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GHSI with unrelated industries.